What is PulseVet?
PulseVet specializes in high-energy focused sound wave therapy systems, providing a sophisticated alternative to traditional surgical interventions for horses, cats, and dogs. The company's core product suite, which includes the PulseVet device and specialized X-Trode handpieces, is engineered to mitigate pain, reduce inflammation, and accelerate tissue healing. By grounding its product development in rigorous, peer-reviewed clinical research, PulseVet has established itself as a trusted partner for veterinary professionals seeking to improve patient outcomes through evidence-based, non-surgical modalities. Their market position is defined by a unique blend of technological innovation and a deep understanding of the physiological requirements of veterinary patients.
How much funding has PulseVet raised?
PulseVet has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PulseVet
PPP
Public-Private Partnership
What's next for PulseVet?
With the successful acquisition of this late-stage capital, PulseVet is well-positioned to expand its global footprint and deepen its penetration into the veterinary pain management market. The strategic deployment of these funds will likely focus on accelerating research and development initiatives to refine existing therapeutic platforms and potentially diversify their product portfolio. As the demand for non-invasive, high-efficacy veterinary treatments continues to rise, PulseVet is poised to leverage its established clinical reputation to capture additional market share. Future growth will likely be driven by enhanced distribution networks and continued investment in clinical validation, ensuring the company remains the gold standard in veterinary shock wave technology.
See full PulseVet company page
